Patents by Inventor Anders Virtanen

Anders Virtanen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-infective heterocyclic compounds and uses thereof
    Patent number: 11130741
    Abstract: The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: September 28, 2021
    Assignee: Bioimics AB
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20210246115
    Abstract: The present invention relates to heterocyclic compounds of Formula F-I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: November 5, 2018
    Publication date: August 12, 2021
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
    Publication number: 20190233384
    Abstract: The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: June 22, 2017
    Publication date: August 1, 2019
    Inventors: Leif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
  • Compounds and methods
    Patent number: 9377466
    Abstract: A molecular tool for use in a method of providing a molecule that is capable of binding a target molecule based on a set of polypeptides. A polypeptide having a sequence selected from SEQ ID NOs 1-32. The polypeptide may be used in a method of screening for a ligand-polypeptide conjugate capable of binding a target molecule for the ligand. A ligand-polypeptide conjugate, useful e.g. in therapy.
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: June 28, 2016
    Assignee: Modpro AB
    Inventors: Lars Baltzer, Adam Slosarczyk, Jonas Bergquist, Anders Virtanen
  • Compounds and Methods
    Publication number: 20130261013
    Abstract: A molecular tool for use in a method of providing a molecule that is capable of binding a target molecule based on a set of polypeptides. A polypeptide having a sequence selected from SEQ ID NOs 1-32. The polypeptide may be used in a method of screening for a ligand-polypeptide conjugate capable of binding a target molecule for the ligand. A ligand-polypeptide conjugate, useful e.g. in therapy.
    Type: Application
    Filed: September 6, 2011
    Publication date: October 3, 2013
    Applicant: MODPRO AB
    Inventors: Lars Baltzer, Adam Slosarczyk, Jonas Bergquist, Anders Virtanen
  • Method and kit for detection of novel pathogen inhibitors
    Patent number: 7794967
    Abstract: The present invention relates to a method for detection of novel pathogen inhibitors using models of pathogen specific, and metal binding structures/domains representing essential cellular molecules. The method enables identification of inhibitors that bind to any specific RNA molecule or protein that are essential for cell growth, proliferation and differentiation. The invention also relates to a kit for use in the method. Furthermore, the invention relates to use of aminoglycosides in the development of new drugs.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: September 14, 2010
    Assignee: Bioimics AB
    Inventors: Anders Virtanen, Leif Kirsebom
  • NOVEL HUMAN POLY(A)POLYMERASE GAMMA (PAP GAMMA)
    Publication number: 20080166732
    Abstract: The present invention relates to a novel human poly(A) polymerase enzyme (PAP), its nucleic and amino acid sequence and use thereof as well as an antibody against the novel enzyme and use thereof. The novel enzyme named PAP? and is not related to the previously known PAPs.
    Type: Application
    Filed: January 31, 2008
    Publication date: July 10, 2008
    Inventors: Anders VIRTANEN, Helena Nordvarg, Christina Kyriakopolou
  • Method and kit for detection of novel pathogen inhibitors
    Publication number: 20050118587
    Abstract: The present invention relates to a method for detection of novel pathogen inhibitors using models of pathogen specific, and metal binding structures/domains representing essential cellular molecules. The method enables identification of inhibitors that bind to any specific RNA molecule or protein that are essential for cell growth, proliferation and differentiation. The invention also relates to a kit for use in the method. Furthermore, the invention relates to use of aminoglycosides in the development of new drugs.
    Type: Application
    Filed: November 21, 2002
    Publication date: June 2, 2005
    Inventors: Anders Virtanen, Leif Kirscbom
  • Novel human poly(a)polymerase gamma (pap gamma)
    Publication number: 20040161762
    Abstract: The present invention relates to a novel human poly(A)polymerase enzyme (PAP), its nucleic and amino acid sequence and use thereof as well as an antibody against the novel enzyme and use thereof. The novel enzyme is named PAP gamma and is not related to the previously known PAPs.
    Type: Application
    Filed: March 11, 2004
    Publication date: August 19, 2004
    Inventors: Anders Virtanen, Helena Nordvarg, Christina Kyriakopolou
  • 3?-exonuclease, production and use thereof
    Patent number: 6451307
    Abstract: The present invention relates to a poly(A)-specific 3′-exonuclease activity which can be obtained by chromatographically purifying a crude extract of animal or human cells and to its use for deadenylating 3′-poly(A) tails of nucleic acids and as a pharmaceutical or diagnostic agent, or for identifying functional interactors.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: September 17, 2002
    Assignee: Aventis Research & Technologies GmbH & Co. KG
    Inventors: Thomas Neumann, Christoph Hüls, Karl-Christian Gallert, Anders Virtanen, Jonas Aström, Javier Martinez, Ann-Charlotte Thuresson, Yanguo Ren